Skip to main content
Premium Trial:

Request an Annual Quote

Chicken Pox, Small Pox … Cancer?

Premium

A team of researchers at Leeds University and the Mayo Clinic have published a new study in Nature Medicine, which suggests that they're close to developing a vaccine to shrink tumors, reports Reuters. The researchers' technique uses a cDNA library from organs in which tumors can form and spread, and early tests on mice with prostate cancer show that the vaccine could eventually be used in human cancer patients, Reuters says, though the team adds that human trials are years away. Several companies are trying to develop therapeutic vaccines — which are meant to treat a disease after it has formed, not prevent it as a traditional vaccine does — for different kinds of cancer. Where this vaccine differs is that because it contains a library of DNA with multiple genes, it could create many different antigens and fight several kinds of cancer, Reuters says.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more